Market Currents
Ligand Pharmaceuticals (LGND -2.3%) trades lower after guiding its FY13 estimates below Street...
-
Tuesday, December 4, 2012, 3:32 PM ETLigand Pharmaceuticals (LGND -2.3%) trades lower after guiding its FY13 estimates below Street consensus at its Analyst Day earlier this morning. The company now expects earn around $0.35 per share on revenue of $41M to $44M, below analysts estimates of $0.43 on $45M. (Webcast replay)
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
